睿智医药：高级管理人员高莹莹辞职

Company Overview - RuiZhi Pharmaceutical (SZ 300149) announced the resignation of Ms. Gao Yingying as the company secretary due to job adjustments [1] - As of the report date, RuiZhi Pharmaceutical has a market capitalization of 4.9 billion yuan [1] Revenue Composition - For the first half of 2025, the revenue composition of RuiZhi Pharmaceutical is as follows: - Pharmaceutical research and development services and production outsourcing account for 99.06% - Prebiotic series accounts for 0.52% - Rental income accounts for 0.35% - Other industries account for 0.07% [1]